NHS National Framework Agreement for the supply of products for the management of Hereditary Angioedema
The NHS Commissioning Board (operating under the name of NHS England)
This tender has closed
The submission deadline for this contract has passed. There may be more active goods tenders from The NHS Commissioning Board (operating under the name of NHS England), and hundreds more across the UK public sector.
Key details
Procurement
- 33600000 Pharmaceutical products
- 33141520 Plasma extracts
- 33141510 Blood products
What happened
The NHS Commissioning Board (operating under the name of NHS England) awarded this contract to Pharming Group on 20 Jun 2022. The contract runs until 31 Dec 2023.
Description
NHS National Framework Agreement for the supply of products for the management of Hereditary Angioedema. The framework will commence on 1 July 2022 for a period of 18 months, with an option or options to extend (at the Authority's discretion) for a period or periods up to 30 months. Total maximum framework agreement including extension options will be no more than 48 months. Please refer to the offer documents for the list of purchasing points.
Awarded supplier
Contact
Identifiers
Explore related tenders
External ID: fts-ocds-h6vhtk-0314ad • Added 20 August 2026